Evidence map›Paper›PMID 15350211›Full record

ArticleBMC molecular biology2004

Coactivators p300 and PCAF physically and functionally interact with the foamy viral trans-activator.

Helmut Bannert, Walter Muranyi, Vasily V Ogryzko, Yoshihiro Nakatani, Rolf M Flügel

Open access · hybridAbstract read
In one paragraph

Article in BMC molecular biology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Helmut BannertDepartment of Retroviral Gene Expression, German Cancer Research Center, Applied Tumor Virology, Heidelberg, Germany. h.bannert@dkfz-heidelberg.de
Walter Muranyi
Vasily V Ogryzko
Yoshihiro Nakatani
Rolf M Flügel
Heidelberg University · DECentre National de la Recherche Scientifique · FRGerman Cancer Research Center · DEHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFoamy virus Bel1/Tas trans-activators act as key regulators of gene expression and directly bind to Bel1 response elements (BRE) in both the internal and the 5'LTR promoters leading to strong transcriptional trans-activation. Cellular coactivators interacting with Bel1/Tas are unknown to date.

resultsTransient expression assays, co-immunoprecipitation experiments, pull-down assays, and Western blot analysis were used to demonstrate that the coactivator p300 and histone acetyltransferase PCAF specifically interact with the retroviral trans-activator Bel1/Tas in vivo. Here we show that the Bel1/Tas-mediated trans-activation was enhanced by the coactivator p300, histone acetyltransferases PCAF and SRC-1 based on the crucial internal promoter BRE. The Bel1/Tas-interacting region was mapped to the C/H1 domain of p300 by co-immunoprecipitation and pull-down assays. In contrast, coactivator SRC-1 previously reported to bind to the C-terminal domain of p300 did not directly interact with the Bel1 protein but nevertheless enhanced Bel1/Tas-mediated trans-activation. Cotransfection of Bel1/Tas and p300C with an expression plasmid containing the C/H1domain partially inhibited the p300C-driven trans-activation.

conclusionsOur data identify p300 and PCAF as functional partner molecules that directly interact with Bel1/Tas. Since the acetylation activities of the three coactivators reside in or bind to the C-terminal regions of p300, a C/H1 expression plasmid was used as inhibitor. This is the first report of a C/H1 domain-interacting retroviral trans-activator capable of partially blocking the strong Bel1/Tas-mediated activation of the C-terminal region of coactivator p300. The potential mechanisms and functional roles of the three histone and factor acetyltransferases p300, PCAF, and SRC-1 in Bel1/Tas-mediated trans-activation are discussed.

Indexed as

AcetyltransferasesCell Cycle ProteinsCell LineCell Line, TumorDNA-Binding ProteinsHeLa CellsHistone AcetyltransferasesHumansKidneyMutationNuclear Proteinsp300-CBP-Associated Factorp300-CBP Transcription FactorsPeptidesProtein Interaction MappingProtein Structure, TertiaryAcetyltransferasesbel1 protein, Human foamy virusCell Cycle ProteinsDNA-Binding ProteinsHistone AcetyltransferasesNuclear Proteinsp300-CBP-Associated Factorp300-CBP Transcription FactorsPeptidesRetroviridae ProteinsTrans-ActivatorsTranscription Factors

Identifiers

PMID15350211
PMCPMC517496
OpenAlexW1906295612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.